.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Fuji
Colorcon
Baxter
Federal Trade Commission
Johnson and Johnson
Merck
Queensland Health
Chubb
Julphar

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201002

« Back to Dashboard
NDA 201002 describes HEPARIN SODIUM, which is a drug marketed by Hospira, Sandoz, Solopak, Watson Labs Inc, West-ward Pharms Int, Sagent Pharms, Lilly, Gland Pharma Ltd, Fresenius Kabi Usa, Chamberlin Parenterl, Abraxis Pharm, Shenzhen Techdow, Smith And Nephew, Dell Labs, Parke Davis, Luitpold, Organon Usa Inc, Watson Labs, Pfizer, Pharmacia And Upjohn, Hospira Inc, Pharm Spec, Akorn, Baxter Hlthcare, Mcgaw, B Braun, and Pharma Serve Ny, and is included in fifty-eight NDAs. It is available from twelve suppliers. Additional details are available on the HEPARIN SODIUM profile page.

The generic ingredient in HEPARIN SODIUM is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for 201002

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 201002

Ingredient-typeHeparin

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/ML
Approval Date:Jun 8, 2011TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Argus Health
Julphar
Cipla
Boehringer Ingelheim
Cantor Fitzgerald
AstraZeneca
Citi
Johnson and Johnson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot